我要投票 中生北控BioSino在基因检测行业中的票数:503
· 外 推 电 报 ·
2025-11-23 07:35:58 星期日

【中生北控BioSino是哪个国家的品牌?】

中生北控BioSino是什么牌子?「中生北控BioSino」是 中生北控生物科技股份有限公司 旗下著名品牌。该品牌发源于北京市,由创始人陈 * 添在1988年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中生北控BioSino品牌出海!将品牌入驻外推网,定制中生北控BioSino品牌推广信息,可以显著提高中生北控BioSino产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

二十世纪七十年代初,中国科学院生物物理研究所主持承担国家824任务,成功的人工合成了酵母丙氨酸转移核糖核酸。为此,生物物理研究所科技人员组建了工具酶研制组,作为国内生命科学领域高水平的研究基地之一,这只科研队伍研制并生产出主要性能指标达到国外同类水平的酶法临床化学检验试剂。随着科研成果转化规模的不断扩大,为满足市场的迫切需要,生物物理所投资成立了中生生化试剂技术开发公司,就此拉开中国生化诊断试剂产业发展的序幕。经过四十五年的成长与蜕变,成为今天的中生北控生物科技股份有限公司。

中生北控生物科技股份有限公司是中国科学院生物物理研究所创办并控股的高新技术企业,以蛋白质产业为主业,主要从事体外诊断产品的研发、生产和销售。自1973年建厂到1988年公司成立以来,始终以满足民生需求为导向,积极推动民族IVD产业的发展,打造产、学、研、用相结合的自主创新体系,探索“国际化、集团化、复合化”的经营模式,构建“系统化、系列化、整体化、智能化”四化一体的全产业链,提升核心竞争力,在行业中处于重要地位。

中生北控公司自研发和生产“酶法诊断单、双试剂”系列产品以来,经过四十五年的发展,建立了完整的生化检测系列产品平台,发展了免疫诊断系列产品、分子诊断系列产品、血球诊断系列产品、医用临床营养诊断系列产品等。公司拥有包括由8位博士、33位硕士组成的能力过硬的科研团队,拥有由国家人事部批准设立的“企业博士后科研工作站”,与国内生命科学领域高水平的科研机构联建的体外诊断工程研究中心,并与国际知名企业开展合作。

中生北控公司根植于中国科学院这片知识创新的沃土,秉承“做诚信人、为天下先”的企业价值观,拥有16000平方米严格按照GMP标准建设的生产基地,产品质量通过了ISO13485体系认证,质量管理和质量控制水平通过ISO/ICE17025:2005《检验与校准实验室能力的通用要求》的认可,获得使用CNAS实验室认可标志。公司在国内拥有500多家代理商和销售商,在全国大部分的省份和海外都设有分支机构,建立了覆盖全国的市场营销网络及技术支持与技术服务体系。



英文翻译:In the early 1970s, the Institute of Biophysics, Chinese Academy of Sciences, took charge of the national 824 task and successfully synthesized yeast alanine tRNA. For this reason, the scientific and technological personnel of the Institute of Biophysics have set up a tool enzyme research group, which is one of the high-level research bases in the field of life science in China. This research team has developed and produced the enzyme clinical chemical test reagents whose main performance indexes reach the same level in foreign countries. With the continuous expansion of the transformation scale of scientific research achievements, in order to meet the urgent needs of the market, the Institute of biophysics has invested in the establishment of the Zhongsheng biochemical reagent technology development company, which has opened the prelude to the development of China's biochemical diagnostic reagent industry. After 45 years of growth and transformation, it has become today's Zhongsheng Beikong Biotechnology Co., Ltd. Zhongsheng Beikong Biotechnology Co., Ltd. is a high-tech enterprise established and controlled by the Institute of Biophysics, Chinese Academy of Sciences. Its main business is protein industry, mainly engaged in the research, development, production and sales of in vitro diagnostic products. Since its establishment in 1973 and its establishment in 1988, the company has always been oriented to meet the needs of the people's livelihood, actively promoting the development of national IVD industry, building an independent innovation system combining production, learning, research and use, exploring the business model of "internationalization, collectivization and compounding", building a whole industrial chain of "systematization, seriation, integration and intelligence", and improving the core Competitiveness, in the industry in an important position. Since the R & D and production of "enzyme diagnosis single and double reagents" series products, after 45 years of development, the company has established a complete biochemical detection series product platform, developed immune diagnosis series products, molecular diagnosis series products, blood cell diagnosis series products, medical clinical nutrition diagnosis series products, etc. The company has an excellent research team composed of 8 doctors and 33 masters, an "enterprise postdoctoral research workstation" approved by the Ministry of human resources of the people's Republic of China, an in vitro diagnostic engineering research center jointly established with domestic high-level scientific research institutions in the field of life sciences, and cooperates with internationally renowned enterprises. Zhongsheng Beikong company is rooted in the fertile land of knowledge innovation of the Chinese Academy of Sciences. It adheres to the enterprise values of "being honest, being the first in the world". It has a 16000 square meter production base built in strict accordance with GMP standards. Its product quality has passed the ISO13485 system certification. Its quality management and quality control level have passed the general requirements for the ability of inspection and calibration laboratories (ISO / ice17025:2005) The CNAs laboratory approval mark is obtained. The company has more than 500 agents and distributors in China, branches in most provinces and overseas, and established a nationwide marketing network, technical support and technical service system.

本文链接: https://www.waitui.com/brand/20a181997.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

《大型网络平台个人信息保护规定(征求意见稿)》公开征求意见

36氪获悉,国家互联网信息办公室、公安部就《大型网络平台个人信息保护规定(征求意见稿)》公开征求意见。征求意见稿提出,大型网络平台服务提供者应当将在中华人民共和国境内运营中收集和产生的个人信息存储在境内。确需向境外提供的,应当符合国家数据出境安全管理有关规定。大型网络平台服务提供者应当按照国家有关规定,健全个人信息出境安全相关技术和管理措施,及时防范、处置个人信息违法违规出境安全风险和威胁。

2小时前

宁德时代与上汽商用车达成深度战略合作

36氪获悉,11月22日,据宁德时代微信公众号,在第21届广州国际车展上,宁德时代与上汽商用车正式宣布达成深度战略合作。双方将围绕“技术共研、生态共建、全球共进”三大方向,在商用车新能源化、智能化领域全面深化合作,共同构建“车、电、站、云”一体化的智慧换电生态与绿色运力体系。

2小时前

北京“十四五”期间企业直接融资超5.6万亿元

据新华社,记者从日前举行的首都“十四五”规划高质量收官系列主题新闻发布会金融业发展成就专场上获悉,“十四五”期间,北京地区多元化融资渠道进一步拓宽,企业实现直接融资超5.6万亿元。金融“五篇大文章”合计贷款余额6.8万亿元,高于人民币各项贷款增速2.1个百分点,为首都经济持续向好和高质量发展营造良好的金融环境。(新华网)

2小时前

李斌:乐道也将有右舵车型

36氪获悉,11月21日,蔚来创始人李斌表示:乐道接下来也会有右舵车型,它需要时间。 今年11月18日,蔚来旗下高端小车品牌萤火虫的右舵车型正式量产,首批将发运至新加坡市场。未来,乐道也将推出右舵车型。

2小时前

鸭绒价格近期仍在高位 中下游追单采购意愿活跃

财联社记者从业内了解到,羽绒服目前进入消费旺季,“(白鸭绒价)10月份几乎是一天一个价,这段时间没有在涨,维持在高位。”尽管多数企业认为当前的原料价格偏高,但由于前期备货不足,促使中下游的追单采购意愿保持活跃。上市公司方面,记者采访获悉华英农业羽绒加工产能满产;古麒绒材当前整体羽绒产能2288吨,公司具备一定数量的鸭绒和鹅绒库存,随着羽绒价格上涨,公司库存相应增值。(财联社)

2小时前

本页详细列出关于中生北控BioSino的品牌信息,含品牌所属公司介绍,中生北控BioSino所处行业的品牌地位及优势。
咨询